Solenis + Diversey:<br/>Stronger Together
Diversey Is Now Part of Solenis
Close 686C6711-FB74-47F4-AFEE-14D0F9C09B39

New Study from Diversey shows That Contact Time and Disinfectant Formulation has a Significant Impact on the Efficacies of Disinfectant Towelettes on Hard, Non-porous Surfaces

June 7, 2023

FOR IMMEDIATE RELEASE

FORT MILL, S.C, June 07, 2023 (PR Newswire). Diversey Holdings, Ltd. (NASDAQ: DSEY), a leading provider of hygiene, infection prevention, and cleaning solutions has demonstrated in a recent study by Purdue University that disinfectant efficacy against Candida auris (C. auris) varied significantly with both product formula and contact time having a significant impact on disinfectant efficacy. The study suggests that healthcare facilities wanting the best hygiene outcomes should use disinfectants with an EPA approved label claim against C. auris and should ensure the surface is kept wet for the contact time listed on the label.

The Diversey funded, peer reviewed Voorn et al. study, selected for its impact on the hygiene and disinfection industry and published in the Scientific Reports journal by Voorn et al. is part of Diversey’s research into disinfection performance to study environmental surfaces and patient care equipment in healthcare facilities. Prior to this research, little was known about disinfectant efficacy against C. auris when wiping larger surfaces, such as would be found in healthcare facilities.

In healthcare, the fungus Candida auris (C. auris) is an emerging pathogen of concern because it can be found on environmental surfaces and is generally more resistant to disinfectants than other Candida species. The authors tested 5 EPA registered disinfectants on a 1 m2 surface that was intentionally contaminated with C. auris. The surface was wiped with a pre-wetted disinfectant wipe and the efficacy against C. auris was measured at contact times from 30 seconds to 10 minutes. There were statistically significant differences in efficacy between different contact times and disinfectants, showing that when healthcare facilities disinfect environmental surfaces, the choice of disinfectant and amount of time the disinfectant keeps the surface wet are likely to have an impact on the amount of C. auris remaining on the surface after disinfection.

Environmental surfaces and patient care equipment in healthcare facilities are routinely contaminated with pathogenic microorganisms, and the standard intervention to treat most healthcare environmental surfaces would be to wipe the surface with an US-EPA approved disinfectant. By wiping a larger surface (1 m2) and testing 5 different commercially available disinfectants used in healthcare facilities (2 with a C. auris claim, 3 without the claim), the authors concluded that there are significant differences in efficacy between products and how keeping the surface wet during disinfection impacted the efficacy.

Visit the Scientific Reports journal for more information on this research.

<div class="line">&nbsp;</div> <h2>About Diversey &ndash; A Solenis Company</h2> <p>At Diversey &ndash; A Solenis Company, we provide cleaning, hygiene products and technologies serving the hospitality, healthcare, food and beverage, food service, retail, and facility management markets. Our services, specialty chemicals and digital solutions enable our customers to conserve natural resources, reduce water and energy use, and minimize waste. Together we remain committed to providing world-class expertise and innovative solutions that help build a cleaner, safer and more sustainable world.</p>
<div class="line">&nbsp;</div> <h2>About Solenis</h2> <p>Solenis is a leading global producer of specialty chemicals focused on delivering sustainable solutions for water-intensive industries, including consumer, industrial, institutional, food and beverage, and pool and spa water markets. Owned by Platinum Equity, the company&rsquo;s product portfolio includes a broad array of water treatment chemistries, process aids, functional additives, and cleaners and disinfectants, as well as state-of-the-art monitoring and control systems. These technologies are used by customers to improve operational efficiencies, enhance product quality, protect plant assets, minimize environmental impact, and create cleaner and safer environments. Headquartered in Wilmington, Delaware, the company has 69 manufacturing facilities strategically located around the globe and employs a team of over 16,100 professionals in 130 countries across six continents. Solenis is a 2024 Best Managed Company Gold Standard honoree, recognized four years in a row.</p> <p>For additional information about Solenis, please visit <a href="/en/">www.solenis.com</a> or follow us on social media.</p>

FOR FURTHER INFORMATION

Global

Catherine (Katy) Abernathy

Vice President, Corporate Communications